311 related articles for article (PubMed ID: 32798606)
1. Use of Multi-Site Radiation Therapy for Systemic Disease Control.
Patel RR; Verma V; Barsoumian HB; Ning MS; Chun SG; Tang C; Chang JY; Lee PP; Gandhi S; Balter P; Dunn JD; Chen D; Puebla-Osorio N; Cortez MA; Welsh JW
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):352-364. PubMed ID: 32798606
[TBL] [Abstract][Full Text] [Related]
2. Is Single-Site Radiation Therapy Enough to Augment the Immune System and Enhance Immunotherapy for Metastatic Disease?
Verma V; Barsoumian HB; Welsh JW
Semin Radiat Oncol; 2024 Jul; 34(3):272-275. PubMed ID: 38880535
[TBL] [Abstract][Full Text] [Related]
3. Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice.
Pieper AA; Rakhmilevich AL; Spiegelman DV; Patel RB; Birstler J; Jin WJ; Carlson PM; Charych DH; Hank JA; Erbe AK; Overwijk WW; Morris ZS; Sondel PM
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34172518
[TBL] [Abstract][Full Text] [Related]
4. The biology of prostate cancer metastases: does oligo differ from polymetastatic?
Sonpavde G
Curr Opin Urol; 2017 Nov; 27(6):542-546. PubMed ID: 28786848
[TBL] [Abstract][Full Text] [Related]
5. Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: A multicenter, international study.
Barzilai O; Versteeg AL; Sahgal A; Rhines LD; Bilsky MH; Sciubba DM; Schuster JM; Weber MH; Pal Varga P; Boriani S; Bettegowda C; Fehlings MG; Yamada Y; Clarke MJ; Arnold PM; Gokaslan ZL; Fisher CG; Laufer I; The Ao Spine Knowledge Forum Tumor
Cancer; 2019 Mar; 125(5):770-778. PubMed ID: 30489634
[TBL] [Abstract][Full Text] [Related]
6. Integration of radiotherapy and immunotherapy for treatment of oligometastases.
Pitroda SP; Chmura SJ; Weichselbaum RR
Lancet Oncol; 2019 Aug; 20(8):e434-e442. PubMed ID: 31364595
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Combining radiation plus immunotherapy to improve systemic immune response.
Cushman TR; Gomez D; Kumar R; Likacheva A; Chang JY; Cadena AP; Paris S; Welsh JW
J Thorac Dis; 2018 Feb; 10(Suppl 3):S468-S479. PubMed ID: 29593892
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiotherapy in oligometastatic cancer.
Kennedy TAC; Corkum MT; Louie AV
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S16. PubMed ID: 28917254
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy Dose in Patients Receiving Immunotherapy.
Fitzgerald KJ; Schoenfeld JD
Semin Radiat Oncol; 2023 Jul; 33(3):327-335. PubMed ID: 37331787
[TBL] [Abstract][Full Text] [Related]
11. The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership.
Chajon E; Castelli J; Marsiglia H; De Crevoisier R
Crit Rev Oncol Hematol; 2017 Mar; 111():124-132. PubMed ID: 28259287
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy in the age of cancer immunology: Current concepts and future developments.
Loi M; Desideri I; Greto D; Mangoni M; Sottili M; Meattini I; Becherini C; Terziani F; Delli Paoli C; Olmetto E; Bonomo P; Livi L
Crit Rev Oncol Hematol; 2017 Apr; 112():1-10. PubMed ID: 28325250
[TBL] [Abstract][Full Text] [Related]
13. Low-dose radiation therapy mobilizes antitumor immunity: New findings and future perspectives.
Zhou L; Liu Y; Wu Y; Yang X; Spring Kong FM; Lu Y; Xue J
Int J Cancer; 2024 Apr; 154(7):1143-1157. PubMed ID: 38059788
[TBL] [Abstract][Full Text] [Related]
14. NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8
Walker JM; Rolig AS; Charych DH; Hoch U; Kasiewicz MJ; Rose DC; McNamara MJ; Hilgart-Martiszus IF; Redmond WL
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457127
[TBL] [Abstract][Full Text] [Related]
15. Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma.
Barsoumian HB; Ramapriyan R; Younes AI; Caetano MS; Menon H; Comeaux NI; Cushman TR; Schoenhals JE; Cadena AP; Reilly TP; Chen D; Masrorpour F; Li A; Hong DS; Diab A; Nguyen QN; Glitza I; Ferrarotto R; Chun SG; Cortez MA; Welsh J
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33106386
[TBL] [Abstract][Full Text] [Related]
16. Advances in radiotherapy in bone metastases in the context of new target therapies and ablative alternatives: A critical review.
Gouveia AG; Chan DCW; Hoskin PJ; Marta GN; Trippa F; Maranzano E; Chow E; Silva MF
Radiother Oncol; 2021 Oct; 163():55-67. PubMed ID: 34333087
[TBL] [Abstract][Full Text] [Related]
17. Abscopal effect of radiotherapy combined with immune checkpoint inhibitors.
Liu Y; Dong Y; Kong L; Shi F; Zhu H; Yu J
J Hematol Oncol; 2018 Aug; 11(1):104. PubMed ID: 30115069
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase II trial of sipuleucel-T immunotherapy preceded by sensitizing radiation therapy and sipuleucel-T alone in patients with metastatic castrate resistant prostate cancer.
Twardowski P; Wong JYC; Pal SK; Maughan BL; Frankel PH; Franklin K; Junqueira M; Prajapati MR; Nachaegari G; Harwood D; Agarwal N
Cancer Treat Res Commun; 2019; 19():100116. PubMed ID: 30682445
[TBL] [Abstract][Full Text] [Related]
19. Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.
Dhondt B; De Bleser E; Claeys T; Buelens S; Lumen N; Vandesompele J; Beckers A; Fonteyne V; Van der Eecken K; De Bruycker A; Paul J; Gramme P; Ost P
World J Urol; 2019 Dec; 37(12):2557-2564. PubMed ID: 30578441
[TBL] [Abstract][Full Text] [Related]
20. Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy.
Blanchard M; Shim KG; Grams MP; Rajani K; Diaz RM; Furutani KM; Thompson J; Olivier KR; Park SS; Markovic SN; Pandha H; Melcher A; Harrington K; Zaidi S; Vile R
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):577-87. PubMed ID: 26461000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
